4.7 Review

Transcriptional control of COX-2 via C/EBPβ

Journal

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 25, Issue 4, Pages 679-685

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.ATV.0000157899.35660.61

Keywords

aspirin; C/EBP; COX-2; inflammation; NF-kappa B

Funding

  1. NHLBI NIH HHS [R01 HL-50675] Funding Source: Medline
  2. NINDS NIH HHS [P50 NS-23327] Funding Source: Medline

Ask authors/readers for more resources

Cyclooxygenase-2 (COX-2) is a highly inducible enzyme exerting diverse actions on cell functions, including proliferation, migration, and DNA damage. Enhanced COX-2 expression may be protective, but excessive expression may be harmful, causing inflammation, atheromatous plaque instability, and intimal hyperplasia. COX-2 transcriptional activation by proinflammatory mediators has been extensively characterized. In this review, the role of C/EBP in regulating COX- 2 transcription is highlighted. Recent advances in control of COX- 2 transcription by aspirin and salicylate and by a cell cycle - dependent endogenous mechanism are described. The recent progress sheds light on the pathophysiological mechanisms of COX- 2 and new transcription-based strategy for controlling COX- 2 overexpression and COX- 2 - mediated cardiovascular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available